There has been a scramble among AIM biotech companies to come up with a potential treatments for Coronavirus. One of the firms is Tiziana Life Sciences #TILS, listed on AIM and Nasdaq.
The shares were in demand on Thursday when it said it had developed new technology to treat COVID-19 infections.
